Share. Connect. Create. Grow. · Socialiya
FDA green lights early access to pancreatic cancer drug, daraxonrasib

The FDA said it will grant some patients early access to Revolution Medicines' experimental pancreat...

HEALTH NEWS May 01, 2026

FDA green lights early access to pancreatic cancer drug, daraxonrasib

The FDA said it will grant some patients early access to Revolution Medicines' experimental pancreatic cancer drug daraxonrasib.

23 views 0 likes 0 comments
Share:
The FDA said it will grant some patients early access to Revolution Medicines' experimental pancreatic cancer drug daraxonrasib.

Author: USA Today

Read Original Article

Related News

Latest News

Advertisement

Top Categories

Advertisement
Advertisement
Advertisement
Advertisement